Affinity Asset Advisors, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001773195

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q3 2024 · 84 positions · Total reported value $701.12M · Top-10 concentration 43.2% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 55.3% · 24 new · 29 cut · 20 exited

Active Share (vs S&P 500): 99.9% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -12.1% · vs SPY -14.3% · Prev Value $2.08B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -2.2% · vs SPY -4.3% · Latest Value $2.15B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2024 13F filing, Affinity Asset Advisors, LLC disclosed 84 equity positions with a combined reported value of $701.12M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 43.2% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2024 were XENE ($45.04M), FLNA ($42.65M), APGE ($39.01M). By sector, the heaviest allocations are Health Care 62.5%, Materials 0.2%. Versus the prior quarter, allocation shifted toward Health Care (+12.7pp) and away from Other (-12.7pp).

Versus the prior quarter, Affinity Asset Advisors, LLC opened 24 new positions, trimmed 29 and fully exited 20, a turnover rate of 55.3% of positions. The portfolio's overlap with the prior quarter was 61% of names.

The largest new positions opened in Q3 2024 were FLNA ($42.65M), ORKA ($8.57M), ANAB ($6.70M).

Of the 20 positions fully exited versus the prior quarter, the largest were SPY ($190.48M), ALNY ($16.20M), CERE ($10.22M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2024)

  • FLNA FILANA THERAPEUTICS INC · $42.65M
  • ORKA ORUKA THERAPEUTICS INC · $8.57M
  • ANAB ANAPTYSBIO INC · $6.70M
  • SPRY ARS PHARMACEUTICALS INC COM · $5.80M
  • ARVN ARVINAS INC · $5.54M
  • TERN TERNS PHARMACEUTICALS INC · $5.00M
  • TVTX TRAVERE THERAPEUTICS INC · $4.32M
  • NVAX NOVAVAX INC · $3.79M

Fully Exited (vs previous quarter)

  • SPY STATE STR SPDR S&P 500 ETF T · prev qtr: $190.48M
  • ALNY ALNYLAM PHARMACEUTICALS INC · prev qtr: $16.20M
  • CERE CEREVEL THERAPEUTICS HLDNG I · prev qtr: $10.22M
  • MORF MORPHIC HLDG INC · prev qtr: $8.54M
  • ELEV ELEVATION ONCOLOGY INC · prev qtr: $3.97M
  • HLVX HILLEVAX INC · prev qtr: $3.84M
  • DYN DYNE THERAPEUTICS INC · prev qtr: $3.53M
  • XBI SPDR SERIES TRUST · prev qtr: $3.48M · history

Insider Transactions (Form 4)

Latest Affinity Asset Advisors, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Affinity Asset Advisors, LLC is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 108 US equity positions with a combined value of $2.08B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-120744 (status: Approved), registered 2021-04-09
  • Regulatory AUM (Form ADV): $2.45B as of 2026-07-27
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 1 hedge funds
  • Website: affinityadv.com

Portfolio Structure

  • 108 positions · $2.08B reported value (Q2 2026)
  • Top 10 holdings = 41.7% of reported value
  • Largest position: ROIV (ROIVANT SCIENCES LTD) at 6.4%
  • Average position size: $19.25M

Sector Tilt

  • Health Care 87.6%
  • Financials 1.3%
  • Materials 0.3%
  • (classified holdings cover 89% of value)

Quarterly Activity

  • Q2 2026: 19 new, 34 added, 31 reduced, 12 exited
  • 24 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 62.5%
Materials 0.2%
Other 37.3%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 1.14M $45.04M 6.42%
6.42%
Add
2 1.45M $42.65M 6.08%
6.08%
New
3 664.20K $39.01M 5.57%
5.57%
Reduce
4 337.50K $34.53M 4.92%
4.92%
Add
5 400.00K $33.40M 4.76%
4.76%
Reduce
6 1.00M $27.99M 3.99%
3.99%
Add
7 100.00K $21.22M 3.03%
3.03%
Reduce
8 400.00K $20.44M 2.92%
2.92%
Reduce
9 860.40K $19.33M 2.76%
2.76%
Reduce
10 435.00K $19.23M 2.74%
2.74%
Add
11 650.00K $18.70M 2.67%
2.67%
Reduce
12 1.00M $18.02M 2.57%
2.57%
Reduce
13 4.50M $16.34M 2.33%
2.33%
Add
14 965.61K $15.44M 2.20%
2.20%
Reduce
15 2.82M $14.76M 2.10%
2.10%
Reduce
16 498.42K $14.66M 2.09%
2.09%
Reduce
17 21.52M $14.64M 2.09%
2.09%
Add
18 687.78K $13.44M 1.92%
1.92%
Add
19 16.62M $13.05M 1.86%
1.86%
Add
20 290.45K $12.57M 1.79%
1.79%
Add
21 525.00K $11.94M 1.70%
1.70%
Add
22 1.40M $11.48M 1.64%
1.64%
Add
23 12.25M $9.62M 1.37%
1.37%
Add
24 349.84K $8.57M 1.22%
1.22%
New
25 1.70M $8.24M 1.18%
1.18%
Reduce
26 161.74K $8.08M 1.15%
1.15%
Add
27 725.11K $7.98M 1.14%
1.14%
Reduce
28 35.00K $7.86M 1.12%
1.12%
Reduce
29 472.39K $7.84M 1.12%
1.12%
Add
30 300.00K $7.64M 1.09%
1.09%
Add
31 1.50M $7.63M 1.09%
1.09%
Reduce
32 80.00K $7.19M 1.02%
1.02%
Hold
33 2.50M $6.82M 0.97%
0.97%
Hold
34 1.50M $6.81M 0.97%
0.97%
Hold
35 200.00K $6.70M 0.96%
0.96%
New
36 500.00K $6.67M 0.95%
0.95%
Reduce
37 325.00K $6.30M 0.90%
0.90%
Add
38 400.00K $5.80M 0.83%
0.83%
New
39 50.00K $5.71M 0.81%
0.81%
Add
40 225.00K $5.54M 0.79%
0.79%
New
41 600.00K $5.00M 0.71%
0.71%
New
42 147.50K $4.73M 0.67%
0.67%
Add
43 263.82K $4.42M 0.63%
0.63%
Hold
44 5.00M $4.32M 0.62%
0.62%
New
45 125.00K $4.25M 0.61%
0.61%
Reduce
46 350.00K $4.24M 0.60%
0.60%
Add
47 300.00K $3.79M 0.54%
0.54%
New
48 50.00K $3.65M 0.52%
0.52%
Add
49 350.00K $3.51M 0.50%
0.50%
Hold
50 1.21M $3.33M 0.47%
0.47%
New

FAQ

What did Affinity Asset Advisors, LLC buy in 2024-Q3?

In its 2024-Q3 13F filing, Affinity Asset Advisors, LLC reported 84 equity positions worth $701.12M in aggregate; its largest disclosed positions were XENE ($45.04M), FLNA ($42.65M), APGE ($39.01M).

How large is Affinity Asset Advisors, LLC's portfolio?

Affinity Asset Advisors, LLC reported $701.12M of long equity holdings across 84 positions as of 2024-Q3. Top-10 holdings account for 43.2% of reported value.

What is Affinity Asset Advisors, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/affinity-asset-advisors/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →